These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 605255)

  • 1. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Lymphocyte tubuloreticular structures--disease activity correlation and sequential studies in systemic lupus erythematosus.
    Klippel JH; Grimley PM; Decker JL; Michelitch HJ
    Arthritis Rheum; 1974; 17(3):322. PubMed ID: 4363488
    [No Abstract]   [Full Text] [Related]  

  • 10. [Whole serum complement in kidney diseases and systemic lupus erythematosus].
    Stein G; Stelzner A; Tanner E
    Z Gesamte Inn Med; 1973 Aug; 28(16):469-76. PubMed ID: 4129087
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases.
    Ruddy S; Everson LK; Schur PH; Austen KF
    J Exp Med; 1971 Sep; 134(3 Pt 2):259s-275s. PubMed ID: 5570752
    [No Abstract]   [Full Text] [Related]  

  • 12. An immunological evaluation of pleural effusions in systemic lupus erythematosus.
    Small P; Frank H; Kreisman H; Wolkove N
    Ann Allergy; 1982 Aug; 49(2):101-3. PubMed ID: 7103145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG
    Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum complement levels in systemic lupus erythematosus].
    Morita M; Nishishita S; Amano T; Ofuji T
    Arerugi; 1971 Mar; 20(3):159-68. PubMed ID: 4101817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of disease activity in patients with systemic lupus erythematosus and administration of adrenal cortex steroids].
    Nobunaga M
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):329-33. PubMed ID: 2332686
    [No Abstract]   [Full Text] [Related]  

  • 20. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement.
    Hauptmann G; Grosshans E; Heid E
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:228. PubMed ID: 4212148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.